Global Travelers Vaccination market growth is projected to reach  US$ 4050 million in 2025 to US$ 6276 million in 2031; it is expected to grow at a CAGR of 7.6% from 2025 to 2031.

Global Travelers Vaccination Market Trends and Analysis 2025-31

The global Travelers Vaccination market size is predicted to grow from US$ 4050 million in 2025 to US$ 6276 million in 2031; it is expected to grow at a CAGR of 7.6% from 2025 to 2031. A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the bodys immune system to recognize the agent as foreign, destroy it, and remember it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation. In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc. The travelers vaccination market is driven by the growing trend of international travel and the increasing awareness of the importance of travel vaccinations. As more people travel across borders for leisure, business, or humanitarian reasons, the risk of exposure to infectious diseases in different regions becomes significant. Travelers vaccination provides essential protection against diseases prevalent in specific destinations, such as yellow fever, typhoid, and hepatitis A. The rise in travel-related health risks and the need for pre-travel health consultations contribute to market growth as travelers seek to safeguard their health during their journeys. Moreover, advancements in vaccine formulations and the availability of combination vaccines have improved convenience and compliance for travelers. However, the market also faces challenges, including ensuring timely and appropriate vaccination before travel, as some vaccines require multiple doses over time. Additionally, addressing vaccine accessibility in remote or underserved areas and overcoming vaccine hesitancy among travelers can pose obstacles for comprehensive travel health protection. To succeed, companies must focus on research and development to offer travel-specific vaccine packages, collaborate with travel agencies and healthcare providers to promote travel health education, and address the challenges to meet the increasing demand for effective and tailored protection for travelers. Infinity Market Research newest research report, the Travelers Vaccination Industry Forecast looks at past sales and reviews total world Travelers Vaccination sales in 2024, providing a comprehensive analysis by region and market sector of projected Travelers Vaccination sales for 2025 through 2031. With Travelers Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Travelers Vaccination industry. This Insight Report provides a comprehensive analysis of the global Travelers Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Travelers Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Travelers Vaccination market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Travelers Vaccination and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Travelers Vaccination. This report presents a comprehensive overview, market shares, and growth opportunities of Travelers Vaccination market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Meningococcal Vaccine &nbsp;&nbsp;&nbsp; Japanese Encephalitis Vaccine &nbsp;&nbsp;&nbsp; Yellow Fever Vaccine &nbsp;&nbsp;&nbsp; Hepatitis Vaccine &nbsp;&nbsp;&nbsp; Cholera Vaccine &nbsp;&nbsp;&nbsp; Other Segmentation by Application: &nbsp;&nbsp;&nbsp; Tourists &nbsp;&nbsp;&nbsp; Students &nbsp;&nbsp;&nbsp; Workers &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; GSK &nbsp;&nbsp;&nbsp; Sanofi Pasteur &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; CNBG &nbsp;&nbsp;&nbsp; Serum Institute of India &nbsp;&nbsp;&nbsp; Biokangtai &nbsp;&nbsp;&nbsp; PaxVax &nbsp;&nbsp;&nbsp; Valneva &nbsp;&nbsp;&nbsp; EuBiologics &nbsp;&nbsp;&nbsp; United Biotech Key Questions Addressed in this Report What is the 10-year outlook for the global Travelers Vaccination market? What factors are driving Travelers Vaccination market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Travelers Vaccination market opportunities vary by end market size? How does Travelers Vaccination break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Travelers Vaccination Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Travelers Vaccination by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Travelers Vaccination by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Travelers Vaccination Segment by Type &nbsp;2.2.1 Meningococcal Vaccine &nbsp;2.2.2 Japanese Encephalitis Vaccine &nbsp;2.2.3 Yellow Fever Vaccine &nbsp;2.2.4 Hepatitis Vaccine &nbsp;2.2.5 Cholera Vaccine &nbsp;2.2.6 Other &nbsp;2.3 Travelers Vaccination Sales by Type &nbsp;2.3.1 Global Travelers Vaccination Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Travelers Vaccination Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Travelers Vaccination Sale Price by Type (2020-2025) &nbsp;2.4 Travelers Vaccination Segment by Application &nbsp;2.4.1 Tourists &nbsp;2.4.2 Students &nbsp;2.4.3 Workers &nbsp;2.4.4 Others &nbsp;2.5 Travelers Vaccination Sales by Application &nbsp;2.5.1 Global Travelers Vaccination Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Travelers Vaccination Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Travelers Vaccination Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Travelers Vaccination Breakdown Data by Company &nbsp;3.1.1 Global Travelers Vaccination Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Travelers Vaccination Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Travelers Vaccination Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Travelers Vaccination Revenue by Company (2020-2025) &nbsp;3.2.2 Global Travelers Vaccination Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Travelers Vaccination Sale Price by Company &nbsp;3.4 Key Manufacturers Travelers Vaccination Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Travelers Vaccination Product Location Distribution &nbsp;3.4.2 Players Travelers Vaccination Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Travelers Vaccination by Geographic Region &nbsp;4.1 World Historic Travelers Vaccination Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Travelers Vaccination Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Travelers Vaccination Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Travelers Vaccination Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Travelers Vaccination Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Travelers Vaccination Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Travelers Vaccination Sales Growth &nbsp;4.4 APAC Travelers Vaccination Sales Growth &nbsp;4.5 Europe Travelers Vaccination Sales Growth &nbsp;4.6 Middle East & Africa Travelers Vaccination Sales Growth 5 Americas &nbsp;5.1 Americas Travelers Vaccination Sales by Country &nbsp;5.1.1 Americas Travelers Vaccination Sales by Country (2020-2025) &nbsp;5.1.2 Americas Travelers Vaccination Revenue by Country (2020-2025) &nbsp;5.2 Americas Travelers Vaccination Sales by Type (2020-2025) &nbsp;5.3 Americas Travelers Vaccination Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Travelers Vaccination Sales by Region &nbsp;6.1.1 APAC Travelers Vaccination Sales by Region (2020-2025) &nbsp;6.1.2 APAC Travelers Vaccination Revenue by Region (2020-2025) &nbsp;6.2 APAC Travelers Vaccination Sales by Type (2020-2025) &nbsp;6.3 APAC Travelers Vaccination Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Travelers Vaccination by Country &nbsp;7.1.1 Europe Travelers Vaccination Sales by Country (2020-2025) &nbsp;7.1.2 Europe Travelers Vaccination Revenue by Country (2020-2025) &nbsp;7.2 Europe Travelers Vaccination Sales by Type (2020-2025) &nbsp;7.3 Europe Travelers Vaccination Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Travelers Vaccination by Country &nbsp;8.1.1 Middle East & Africa Travelers Vaccination Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Travelers Vaccination Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Travelers Vaccination Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Travelers Vaccination Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Travelers Vaccination &nbsp;10.3 Manufacturing Process Analysis of Travelers Vaccination &nbsp;10.4 Industry Chain Structure of Travelers Vaccination 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Travelers Vaccination Distributors &nbsp;11.3 Travelers Vaccination Customer 12 World Forecast Review for Travelers Vaccination by Geographic Region &nbsp;12.1 Global Travelers Vaccination Market Size Forecast by Region &nbsp;12.1.1 Global Travelers Vaccination Forecast by Region (2026-2031) &nbsp;12.1.2 Global Travelers Vaccination Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Travelers Vaccination Forecast by Type (2026-2031) &nbsp;12.7 Global Travelers Vaccination Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 GSK &nbsp;13.1.1 GSK Company Information &nbsp;13.1.2 GSK Travelers Vaccination Product Portfolios and Specifications &nbsp;13.1.3 GSK Travelers Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 GSK Main Business Overview &nbsp;13.1.5 GSK Latest Developments &nbsp;13.2 Sanofi Pasteur &nbsp;13.2.1 Sanofi Pasteur Company Information &nbsp;13.2.2 Sanofi Pasteur Travelers Vaccination Product Portfolios and Specifications &nbsp;13.2.3 Sanofi Pasteur Travelers Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Sanofi Pasteur Main Business Overview &nbsp;13.2.5 Sanofi Pasteur Latest Developments &nbsp;13.3 Merck &nbsp;13.3.1 Merck Company Information &nbsp;13.3.2 Merck Travelers Vaccination Product Portfolios and Specifications &nbsp;13.3.3 Merck Travelers Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Merck Main Business Overview &nbsp;13.3.5 Merck Latest Developments &nbsp;13.4 Pfizer &nbsp;13.4.1 Pfizer Company Information &nbsp;13.4.2 Pfizer Travelers Vaccination Product Portfolios and Specifications &nbsp;13.4.3 Pfizer Travelers Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Pfizer Main Business Overview &nbsp;13.4.5 Pfizer Latest Developments &nbsp;13.5 CNBG &nbsp;13.5.1 CNBG Company Information &nbsp;13.5.2 CNBG Travelers Vaccination Product Portfolios and Specifications &nbsp;13.5.3 CNBG Travelers Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 CNBG Main Business Overview &nbsp;13.5.5 CNBG Latest Developments &nbsp;13.6 Serum Institute of India &nbsp;13.6.1 Serum Institute of India Company Information &nbsp;13.6.2 Serum Institute of India Travelers Vaccination Product Portfolios and Specifications &nbsp;13.6.3 Serum Institute of India Travelers Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Serum Institute of India Main Business Overview &nbsp;13.6.5 Serum Institute of India Latest Developments &nbsp;13.7 Biokangtai &nbsp;13.7.1 Biokangtai Company Information &nbsp;13.7.2 Biokangtai Travelers Vaccination Product Portfolios and Specifications &nbsp;13.7.3 Biokangtai Travelers Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Biokangtai Main Business Overview &nbsp;13.7.5 Biokangtai Latest Developments &nbsp;13.8 PaxVax &nbsp;13.8.1 PaxVax Company Information &nbsp;13.8.2 PaxVax Travelers Vaccination Product Portfolios and Specifications &nbsp;13.8.3 PaxVax Travelers Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 PaxVax Main Business Overview &nbsp;13.8.5 PaxVax Latest Developments &nbsp;13.9 Valneva &nbsp;13.9.1 Valneva Company Information &nbsp;13.9.2 Valneva Travelers Vaccination Product Portfolios and Specifications &nbsp;13.9.3 Valneva Travelers Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Valneva Main Business Overview &nbsp;13.9.5 Valneva Latest Developments &nbsp;13.10 EuBiologics &nbsp;13.10.1 EuBiologics Company Information &nbsp;13.10.2 EuBiologics Travelers Vaccination Product Portfolios and Specifications &nbsp;13.10.3 EuBiologics Travelers Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 EuBiologics Main Business Overview &nbsp;13.10.5 EuBiologics Latest Developments &nbsp;13.11 United Biotech &nbsp;13.11.1 United Biotech Company Information &nbsp;13.11.2 United Biotech Travelers Vaccination Product Portfolios and Specifications &nbsp;13.11.3 United Biotech Travelers Vaccination Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 United Biotech Main Business Overview &nbsp;13.11.5 United Biotech Latest Developments 14 Research Findings and Conclusion

Report	Global Travelers Vaccination Market Growth 2025-2031
Selected License	Single ID:LPI13669

Buyer Information

Order Summary